Genelux (GNLX) Revenue (2022 - 2024)
Genelux (GNLX) recorded quarterly Revenue of $8000.0 in Q1 2024, down 95.29% quarter-over-quarter from $170000.0 in Q1 2023, and down 95.29% on a YoY basis from $170000.0 in Q2 2023.
Genelux (GNLX) Revenue (2022 - 2024) Analysis & Trends
Genelux's Revenue history runs 3 years deep, the most recent figure standing at $8000.0 for Q1 2024.
- In Q1 2024, Revenue fell 95.29% year-over-year to $8000.0; the TTM figure through Dec 2024 stood at $8000.0 (down 95.29% YoY), while the FY2025 annual figure was $8000.0, changed 0.0% from the prior year.
- Revenue was $8000.0 for Q1 2024 at Genelux, down from $170000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $11.0 million in Q3 2022 to a low of -$10.8 million in Q4 2022.
- Historically, Revenue has averaged $87000.0 across 3 years, with a median of $89000.0 in 2023.
- Biggest YoY gain for Revenue was 95.29% in 2024; the steepest drop was 95.29% in 2024.
- A 3-year view of Revenue shows it stood at -$10.8 million in 2022, then surged by 101.57% to $170000.0 in 2023, then slumped by 95.29% to $8000.0 in 2024.
- The last three Revenue figures came in at $8000.0 (Q1 2024), $170000.0 (Q1 2023), and -$10.8 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2023 | 170,000.00 |
| Dec 31, 2022 | -10.83 Mn |
| Sep 30, 2022 | 11.00 Mn |